← Leaderboards
Richard N Fedorak
Sloan-Kettering Inst Can Research
$135,271
Attributed
$405,813
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$405,813 · 1
By mechanism
UG3$405,813 · 1
Top collaborators
- Olusegun Isaac Alatise1 shared
- T Peter Kingham1 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- T Peter Kingham$2,940,023
- Olusegun Isaac Alatise$2,073,530
- Mengmeng Du$2,352,665
- Richard John Bennett$14,709,057
- David Wishart$3,311,142
Others in their field
Other Emerging Leaders on “Advanced Malignant Neoplasm”
- Leonard Freedman · Leidos Biomedical Research, Inc.$354,493,986
- Leonard Freedmand · Leidos Biomedical Research, Inc.$79,963,641
- Lynn Briscoe · Leidos Biomedical Research, Inc.$47,097,978
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Stephen F Kry · University Of Tx Md Anderson Can Ctr$28,689,457
- Tareq Al Baghdadi · Saint Joseph Mercy Health System$19,225,531
Research focus
Advanced Malignant NeoplasmAdvisory CommitteesAge-YearsAlberta ProvinceBaseBedside TestingsBeliefBenignBiobankBiosensorBusinessesCanadaCancer CareCancer ControlCancer DiagnosisCancer DiagnosticsClinical TrialsClinics And HospitalsCollegeColon Cancer PatientsColonoscopyColorectal CancerColorectal Cancer PreventionAdvanced Disease